Taipei Veterans General Hospital

:::

黃以信 (Yi-Shin Huang)

Return Appointment First Appointment

[Profile]

Education
Career and Experience
Current Positions：
- - Now, Attending Physician, Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
- - Now, Professor, National Yang-Ming University School of Medicine, Taipei, Taiwan,
Experiences：
- - , Visiting Scientist, Department of Biochemistry, School of Public Health, Johns Hopkins University, Baltimore, MD, USA,
- - , Chief Resident, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
- - , Resident, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan,
Medical Expertise
1. Chronic hepatitis B and C
2. Liver cirrhosis – diagnosis & treatment
3. Hepatocellular carcinoma – diagnosis & treatment
4. Abdominal ultrasound and GI tract endoscopy
License

Board-certified Physician, Diploma of Department of Health, Executive Yuan, Taiwan Board-certified Gastroenterologist and Instructor, Diploma of The Gastroenterological Society of Taiwan Board-certified Digestive Endoscopist and Instructor, Diploma of The Digestive Endoscopy Society of Taiwan

[Publications]

1. Huang YS, et al. Genetic variations of superoxide dismutase 2 and cytochrome P450 2E1 in non-alcoholic steatohepatitis. Liver Int 2014;34:931-6.
2. Huang YS, et al. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H: quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 2007; 47:128-34.
3. Huang YS, et al. Cytochrome P450 2E1 genetic polymorphism and the susceptibility to anti-tuberculosis drug-induced hepatitis. Hepatology 2003; 37: 924-30.
4. Huang YS, et al. Polymorphism of the N-acetyltransferase 2 gene, red meat intake and the susceptibility of hepatocellular carcinoma. Am J Gastroenterol 2003; 98:1417-22.
5. Huang YS, et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor of antituberculosis drug-induced hepatitis. Hepatology 2002; 35: 883-9.